Dermata is a development-stage biotechnology company founded in late 2014 focused on making major advancements in the treatment of serious diseases treated by dermatologists, with a focus on inflammation and immunology.
Our business strategy is to identify and develop innovative products that we can quickly move into clinical trials to demonstrate efficacy and safety in a variety of diseases. We are currently exploring the use of a new chemical entity with a novel drug formulation to deliver drug into the site of the disease for targeted treatment. With multiple dermatologic diseases being investigated, we have begun to build a strong pipeline that will create significant value for our stockholders. We believe this strategy will enable us to build a platform of products that we can efficiently move from R&D, through development and into commercialization with an attractive capital return.
|HQ||San Diego, CA, US||Map|
Dermata Therapeutics total Funding
Dermata Therapeutics latest funding size
Time since last funding
|4 years ago|
Dermata Therapeutics investors
|Silicon Valley Bank|
When was Dermata Therapeutics founded?
Dermata Therapeutics was founded in 2014.
Who are Dermata Therapeutics key executives?
Dermata Therapeutics's key executives are Gerry Proehl, Tom Insley and Chris Nardo.
Who are Dermata Therapeutics competitors?
Competitors of Dermata Therapeutics include Biogen, MyoKardia and Athersys.
Where is Dermata Therapeutics headquarters?
Dermata Therapeutics headquarters is located at 3525 Del Mar Heights Rd #322, San Diego.
Where are Dermata Therapeutics offices?
Dermata Therapeutics has an office in San Diego.
How many offices does Dermata Therapeutics have?
Dermata Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies